This company has been acquired
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
LogicBio Therapeutics 관리
관리 기준 확인 1/4
주요 정보
Fred Chereau
최고 경영자
US$2.2m
총 보상
| CEO 급여 비율 | 24.3% |
| CEO 임기 | 6.6yrs |
| CEO 소유권 | 0.8% |
| 경영진 평균 재임 기간 | 1.8yrs |
| 이사회 평균 재임 기간 | 3.4yrs |
최근 관리 업데이트
Recent updates
LogicBio jumps 648% on buyout deal with AstraZeneca unit Alexion
Oct 03Bullish: Analysts Just Made A Notable Upgrade To Their LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Forecasts
Aug 20
LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates
Aug 18LogicBio GAAP EPS of -$0.15, revenue of $3.2M
Aug 15Is LogicBio Therapeutics (NASDAQ:LOGC) Weighed On By Its Debt Load?
Jan 11Does LogicBio Therapeutics (NASDAQ:LOGC) Have A Healthy Balance Sheet?
Aug 18LogicBio EPS misses by $0.06, beats on revenue
May 10LogicBio announces agreements with CANbridge Pharma and Daiichi Sankyo
Apr 27Is LogicBio Therapeutics (NASDAQ:LOGC) Using Debt Sensibly?
Apr 12Is LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Popular Amongst Insiders?
Mar 08The LogicBio Therapeutics (NASDAQ:LOGC) Share Price Has Gained 12% And Shareholders Are Hoping For More
Jan 15LogicBio extends collaboration with Children's Medical Research Institute
Jan 07LogicBio Therapeutics names new CFO
Dec 22Looking In On LogicBio
Nov 17LogicBio reports Q3 results
Nov 09CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$27m |
| Jun 30 2022 | n/a | n/a | -US$31m |
| Mar 31 2022 | n/a | n/a | -US$36m |
| Dec 31 2021 | US$2m | US$543k | -US$40m |
| Sep 30 2021 | n/a | n/a | -US$38m |
| Jun 30 2021 | n/a | n/a | -US$36m |
| Mar 31 2021 | n/a | n/a | -US$33m |
| Dec 31 2020 | US$2m | US$479k | -US$33m |
| Sep 30 2020 | n/a | n/a | -US$37m |
| Jun 30 2020 | n/a | n/a | -US$40m |
| Mar 31 2020 | n/a | n/a | -US$42m |
| Dec 31 2019 | US$633k | US$510k | -US$40m |
| Sep 30 2019 | n/a | n/a | -US$32m |
| Jun 30 2019 | n/a | n/a | -US$29m |
| Mar 31 2019 | n/a | n/a | -US$23m |
| Dec 31 2018 | US$2m | US$411k | -US$18m |
| Sep 30 2018 | n/a | n/a | -US$18m |
| Jun 30 2018 | n/a | n/a | -US$11m |
| Mar 31 2018 | n/a | n/a | -US$9m |
| Dec 31 2017 | US$779k | US$385k | -US$8m |
보상 대 시장: Fred's total compensation ($USD2.23M) is above average for companies of similar size in the US market ($USD750.11K).
보상과 수익: Fred's compensation has increased whilst the company is unprofitable.
CEO
Fred Chereau (55 yo)
6.6yrs
테뉴어
US$2,228,208
보상
Mr. Frederic Chereau, M.B.A., also known as Fred, is the Chairman of the Board of Coave Therapeutics since October 2022 and has been its Independent Non-Executive Director since October 2021. He has execut...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 6.6yrs | US$2.23m | 0.77% $ 525.4k | |
| Co-Founder | no data | US$156.64k | 2.38% $ 1.6m | |
| Chief Medical Officer | 2.4yrs | US$1.54m | 0.010% $ 6.9k | |
| Co-Founder & Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Co-Founder | 8.3yrs | 데이터 없음 | 데이터 없음 | |
| Interim CFO | less than a year | 데이터 없음 | 데이터 없음 | |
| Global VP & Head of Technology Development | 3.6yrs | 데이터 없음 | 데이터 없음 | |
| Chief Scientific Officer | 2yrs | US$1.34m | 데이터 없음 | |
| General Counsel & Corporate Secretary | 1.5yrs | 데이터 없음 | 데이터 없음 | |
| VP & Head of Human Resources | 1.2yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Strategy & Portfolio Management | 1.4yrs | 데이터 없음 | 데이터 없음 | |
| Chief Business Officer | 1.3yrs | 데이터 없음 | 데이터 없음 |
1.8yrs
평균 재임 기간
55yo
평균 연령
경험이 풍부한 관리: LOGC's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | no data | US$2.23m | 0.77% $ 525.4k | |
| Co-Founder | 6.8yrs | US$156.64k | 2.38% $ 1.6m | |
| Co-Founder & Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 4.2yrs | US$87.39k | 0.0095% $ 6.5k | |
| Independent Chairman of the Board | 4.1yrs | US$113.64k | 0.012% $ 8.1k | |
| Independent Director | 2.7yrs | US$82.02k | 0.0089% $ 6.0k | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 6.8yrs | US$81.14k | 0.068% $ 46.2k | |
| Independent Director | 1.9yrs | US$76.77k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$79.64k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | less than a year | US$40.31k | 데이터 없음 |
3.4yrs
평균 재임 기간
58yo
평균 연령
경험이 풍부한 이사회: LOGC's board of directors are considered experienced (3.4 years average tenure).